At Initial Cancer Diagnosis, a Deeply Personalized Assessment

UC San Diego researchers report that conducting genomic evaluations of advanced malignancies can be effective in guiding first-line-of-treatment, rather than waiting until standard-of-care therapies have failed.

Click here to view original post